Adage Capital Partners’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Adage Capital Partners’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-300,000	Closed	-$3.41M	–	980
2023 Q4	$3.41M	Buy	+300,000	New	+$2.36M	0.01%	715

Adage Capital Partners's HARP Position: Q1 2024 in Review

Adage Capital Partners sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 300,000 shares — an estimated $3.41M sold.

Adage Capital Partners first reported a position in HARP in Q4 2023 and held it in 1 quarter. The position peaked at $3.41M in Q4 2023. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Adage Capital Partners reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Adage Capital Partners sold 300,000 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.41M.
Adage Capital Partners first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Adage Capital Partners's Harpoon Therapeutics, Inc. Common Stock position peaked at $3.41M in Q4 2023.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Adage Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.